Phenazine

Phenazine

SCHEMBL2923781

O=S(=O)(O)O.c1ccc2nc3ccccc3nc2c1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phenazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.65
ALDH1A1 P00352 7/20 0.50
NQO2 P16083 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
KMT2A Q03164 2/20 0.46
GAA P10253 2/20 0.46
RAB9A P51151 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 2/20 0.46
POLB P06746 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
CACNA1B Q00975 1/20 0.46
APBA1 Q02410 1/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 2/20 0.46
GLA P06280 1/20 0.46
ACHE P22303 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenazine SCHEMBL8564741 1.00 MAPT (0.65) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL28835271 0.97 MAPT (0.61) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL23522712 0.89 MAPT (0.58) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL1750964 0.89 MAPT (0.58) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL23522711 0.89 MAPT (0.58) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL28366239 0.87 MAPT (0.55) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL22631548 0.87 MAPT (0.55) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Phenazine SCHEMBL28658053 0.87 MAPT (0.55) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Acridine SCHEMBL10831095 0.85 ALDH1A1 (0.71) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1
Acridine SCHEMBL11600717 0.85 ALDH1A1 (0.71) MAPTALDH1A1NQO2SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180180587-A1 PAPER MICROFLUIDIC DEVICES FOR DETECTION OF IMPROVISED EXPLOSIVES THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2018-06-28 US claimed
US-9891207-B2 Paper microfluidic devices for detection of improvised explosives THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2018-02-13 US claimed
US-20160139102-A1 PAPER MICROFLUIDIC DEVICES FOR DETECTION OF IMPROVISED EXPLOSIVES THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2016-05-19 US claimed
CN-114096563-B Antibodies that specifically bind to B7-H3 and uses thereof Y生物股份有限公司 2025-04-18 CN disclosed
WO-2024249566-A1 NOVEL BIOBATTERY AND ITS USE FOR POWERING APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2024-12-05 WO disclosed
CN-113993897-B Anti-TIE 2 antibodies and uses thereof 药物抗体公司 2024-06-07 CN disclosed
CN-116670273-A Method for measuring in a biosensor 北卡罗来纳大学教堂山分校 2023-08-29 CN disclosed
CN-116236481-A Application of Dp44mT in preparation of anti-candida albicans drugs 上海市同济医院 2023-06-09 CN disclosed
EP-4018791-A1 METHOD OF PREPARING A HIGH DENSITY INTERCONNECT PRINTED CIRCUIT BOARD INCLUDING MICROVIAS FILLED WITH COPPER Atotech Deutschland GmbH & Co. KG (DE) 2022-06-29 EP disclosed
CN-114466658-A Orally delivered therapeutic compositions and uses thereof 沈海发 2022-05-10 CN disclosed
WO-2022062380-A1 TIBETAN GANODERMA LUCIDUM POLYSACCHARIDE GLP-1 WITH ANTIOXIDANT EFFECT, PREPARATION METHOD AND USE 广东省微生物研究所(广东省微生物分析检测中心) 2022-03-31 WO disclosed
US-20030178998-A1 Enzyme electrode ASAHI KASEI KABUSHIKI KAISHA (JP) 2003-09-25 US disclosed
EP-1321763-A1 ENZYME ELECTRODE Asahi Kasei Kabushiki Kaisha (JP) 2003-06-25 EP disclosed
CN-1416354-A Vascular endothelial growth factor 2 HUMAN GENOME SCIENCES INC (US) 2003-05-07 CN disclosed
US-5909114-A Coulometric analysis method and a device therefor NAKANO VINEGAR CO., LTD. (JP) 1999-06-01 US disclosed
US-5726565-A FOR QUANTITATIVE DETERMINATION OF A SAMPLE SUBSTANCE NAKANO VINEGAR CO., LTD. (JP) 1998-03-10 US disclosed
US-5334508-A A mixture reagent consisting of an oxidoreductase enzyme, an aromatic nitroso or a oxime compound and a couplers; free of reducing catalysts, side-effect reduction BOEHRINGER MANNHEIM GMBH (DE) 1994-08-02 US disclosed
EP-0600607-A2 Coulometric analysis method and a device therefor NAKANO VINEGAR CO., LTD. (JP) 1994-06-08 EP disclosed
US-5206147-A COLORIMETRIC ASSAY BY ENZYMATIC OXIDATION IN THE PRESENCE OF AN AROMATIC NITROSO OR OXIME COMPOUND BOEHRINGER MANNHEIM GMBH (DE) 1993-04-27 US disclosed
US-4788141-A BLOOD; HEPATITIS TESTING MARUHO CO., LTD. (JP) 1988-11-29 US disclosed